Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study.

about

Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study.

Item

http://www.wikidata.org/entity/Q36614418

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Phase I/II trial of doxorubici ...... tissue sarcomas: a GEIS study.

@ast

Phase I/II trial of doxorubici ...... tissue sarcomas: a GEIS study.

@en

type

Item

label

Phase I/II trial of doxorubici ...... tissue sarcomas: a GEIS study.

@ast

Phase I/II trial of doxorubici ...... tissue sarcomas: a GEIS study.

@en

prefLabel

Phase I/II trial of doxorubici ...... tissue sarcomas: a GEIS study.

@ast

Phase I/II trial of doxorubici ...... tissue sarcomas: a GEIS study.

@en

P1476

Phase I/II trial of doxorubici ...... tissue sarcomas: a GEIS study

@en

P2093

A Casado

http://www.w3.org/2001/XMLSchema#string

A López-Pousa

http://www.w3.org/2001/XMLSchema#string

A Poveda

http://www.w3.org/2001/XMLSchema#string

J Fra

http://www.w3.org/2001/XMLSchema#string

J García Del Muro

http://www.w3.org/2001/XMLSchema#string

J M Buesa

http://www.w3.org/2001/XMLSchema#string

J Martín

http://www.w3.org/2001/XMLSchema#string

J Martínez-Trufero

http://www.w3.org/2001/XMLSchema#string

J Maurel

http://www.w3.org/2001/XMLSchema#string

M Sierra

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas.

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I-II trial.

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.

A phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors.

Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors.

Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma.

P2888

sj.bjc.6603187

P304

1797-1802

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6603187

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carmen Balaña

E Esteban

P577

2006-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232803488

http://www.w3.org/2001/XMLSchema#string

P698

16721358

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

phase II clinical trial

P932

2361345

http://www.w3.org/2001/XMLSchema#string